Idexx Laboratories (IDXX) Depreciation & Amortization (CF) (2009 - 2026)

Idexx Laboratories has reported Depreciation & Amortization (CF) for 18 years, with the latest figure at $41.1 million in Q2 2026.

• On a quarterly basis, Depreciation & Amortization (CF) rose 14.76% year-over-year to $41.1 million in Q2 2026; TTM through Jun 2026 was $154.1 million, a 11.92% increase from a year earlier, with the FY2025 full-year figure at $145.2 million, up 11.73% from the prior year.
• Depreciation & Amortization (CF) was $41.1 million for Q2 2026 at Idexx Laboratories, up from $37.7 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $41.1 million in Q2 2026, with the low at $26.5 million in Q1 2022.
• Average Depreciation & Amortization (CF) over 5 years is $32.3 million, with a median of $31.0 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Depreciation & Amortization (CF) decreased 0.95% in 2023, then gained 17.76% in 2024.
• Over 5 years, Depreciation & Amortization (CF) stood at $28.7 million in 2022, then advanced by 3.54% to $29.7 million in 2023, then rose by 13.35% to $33.7 million in 2024, then grew by 14.88% to $38.7 million in 2025, then grew by 6.02% to $41.1 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $41.1 million (Q2 2026), $37.7 million (Q1 2026), and $38.7 million (Q4 2025), per Business Quant data.